I also take estradiol valerate and my levels range anywhere from 1,300 pg/ml to 4,000 pg/ml. I feel good, have had good overall feminization except for breast growth. I've had several blood tests done and every single time, everything comes back normal (liver enzymes, clotting times, lipids, insulin, C-reactive protein, etc.). I know other transwomen on such high levels whose test results came back normal.
Consider pregnant women whose levels can go as high as 75,000 pg/ml and whose risk of blood clots is less than 0.2%. All verified by studies.
Then, you have male prostate cancer patients, between the ages of 45(49)-91 yrs old, who, when treated with high doses of estradiol, had levels in the range of 400-approx. 700 pg/ml. Despite this, there was no increase in thromboembolic or cardiovascular complications except for one study where the rate was only 2.2%. Considering these men are at an advanced age, have a greater risk of DVT (due to having cancer also), these results are quite positive.
Finally, there are studies (
Horm Metab Res. 1994 Sep;26(9):428-31 AND
Adolesc Pediatr Gynecol (1995) 8:20-23) where pseudopregnancy levels were attained with very high doses of estradiol valerate in ciswomen, some around the age 45-55 yrs old. Levels ranged from "3226 +/- 393 pg/ml after 3 months and to 2552 +/- 254 pg/ml after 6 months" in one group and in the other from "3028 +/- 728 after 3 and to 2491 +/- 684 pg/ml after 6 months."
Their statements:
"We have experience with therapeutic pseudopregnancy in about 200 patients with mammahypoplasia (Lauritzen 1992). Its rate of objective and subjective tolerance is excellent."
"Investigations of lipids, liver enzymes and haemostasiology to be published later will show the absence of unwanted metabolic effects of this regimen."
"In conclusion, our data show, that the treatment (...) by means of high parenteral estrogen-progestogen depot injections is effective. Virtually no side effects occurred. The therapy is well accepted by the patients."
In the other study, estradiol levels ranged from 920 – 6789 pg/ml, in women aged 16-30 yrs old. Despite this,
"High-dose intramuscular injections of estrogen and progestogen were well tolerated. (...) All six patients completed the treatment and some were eager to continue therapy."
Hum Reprod. 2002 Mar;17(3):825-9."We examined metabolic parameters in cohorts of women with and without subcutaneous estrogen therapy with concomitant
supra-normal concentrations of estradiol (SE)."
Apparently from 400-1,000 pg/ml.
CLIMACTERIC 2005;8(Suppl 1):3–63"the estradiol levels were measured in these women to be extremely high (between 400 and
1000 pg/ml)149."
"Women with SE have similar triglyceride and HDL cholesterol levels but lower LDL cholesterol concentrations compared with post-menopausal women not taking ERT. The observations that the SE group showed reduced fasting insulin and WHR suggest that supra-normal circulating concentrations of estradiol, delivered subcutaneously, may beneficially influence insulin metabolism."
Also,
J Lipid Res. 2006 Feb;47(2):349-55."This prospective pilot study of 18 men with androgen-independent prostate cancer receiving ADT measured effects of TDE on lipid and inflammatory CVD risk factors before and after 8 weeks of TDE. During treatment, estradiol levels rose 17-fold; total cholesterol, LDL cholesterol, and apolipoprotein B levels decreased. HDL2 cholesterol increased, with no changes in triglyceride or VLDL cholesterol levels. Dense LDL cholesterol decreased and LDL buoyancy increased in association with a decrease in HL activity. Highly sensitive C-reactive protein levels and other inflammatory markers did not worsen. Compared with ADT, short-term TDE therapy of prostate cancer improves lipid levels without deterioration of CVD-associated inflammatory markers and may, on longer-term follow-up, improve CVD and mortality rates."
These men, as previously mentioned, had high levels of estradiol, in this study, mean levels of "460.7 pg/mL (range, 334.6-586.7 pg/mL)."
TDE = transdermal estradiol
ADT = androgen deprivation therapy
Reports also from transsexual women with levels in the thousands, as high 6-7k, with no negative impact on metabolic, cardiovascular markers, some in their 50's.
Two other studies of interest:
Am J Obstet Gynecol. 1993 Dec;169(6):1549-53."As serum estradiol levels increased throughout each phase (maximum mean estradiol 739.8 pg/ml)"
"Down-regulation of the fibrinolytic system was observed as estradiol levels increased. However, thrombin formation did not change, thus suggesting that
elevated circulating estradiol alone does not predispose to a thromboembolic event."
Br J Obstet Gynaecol. 1990 Oct;97(10):917-21.
"There is some anxiety about the possible harmful sequelae of supraphysiological estradiol levels but no data are currently available to show any deleterious effects of these levels on coagulation factors, blood pressure, glucose tolerance or the occurrences of endometrial or breast cancer (Hammond et al. 1974; Thom et id. 1978; Studd B Thom 1981; Armstrong 1988)."
Hence, if your concern is health, then the above suggests you shouldn't be too worried, especially considering you're under the supervision of a doctor (I am supervised by three, of whom two are specialists in the matter).
If you find your libido too low, it could be temporary as your body adjusts to the changes. My T is very low, 8 ng/dl, free T undetectable and I have libido, amazing orgasms and do ejaculate although post-op. The hair loss might be due to significant hormonal changes and only be temporary or to the stress that you go through when you go through any change, positive or negative, which is normal.
Hope this info is helpful. Best of luck.

Quote from: Sophia Sage on October 29, 2016, 09:26:16 AM
Estradiol cypionate, on the other hand, takes longer to "cleave"
Longer to cleave or longer to separate from oil depot because of longer ester which is more lipohilic or both. I have never come across evidence suggesting EC takes longer to cleave relative to EV. The reason for milder peaks and valleys could simply be due to the ester being more lipophilic.